Asia Pacific Prescription Drugs Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Branded and Generics), Drug Type (Small Molecule and Biologics and Biosimilar), Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Diseases, Metabolic Diseases, Respiratory Diseases, Immunology, and Others), Route of Administration (Oral, Injectable, Topical, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
The Asia Pacific Prescription Drugs Market is projected to grow significantly, reaching an estimated US$ 508.7 billion by 2031, up from US$ 304.0 billion in 2024. This growth represents a compound annual growth rate (CAGR) of 7.7% from 2025 to 2031.
Executive Summary and Market Analysis
A key driver of this market expansion is the region's large and aging population, which has led to an increased demand for chronic disease management and long-term medication. The rise in lifestyle-related diseases has further intensified the need for effective prescription drugs. Additionally, improvements in healthcare infrastructure and increased access to medical facilities in developing countries such as India, China, and various Southeast Asian nations have broadened the availability of prescription medications to previously underserved populations.
The growing disposable incomes and the expanding middle class in these countries have enhanced affordability and willingness to invest in healthcare, including prescription drugs. Many governments in the Asia Pacific region have prioritized healthcare reforms and increased healthcare spending, which has led to better insurance coverage and reimbursement policies that support the consumption of pharmaceuticals.
Technological advancements and the growth of research and development in the pharmaceutical sector have resulted in the introduction of innovative and targeted therapies, attracting more patients and healthcare providers to prescribed medications. The increasing awareness and adoption of modern healthcare practices, along with urbanization and lifestyle changes, have also contributed to the rising demand for prescription drugs. Furthermore, the emergence of digital health platforms and telemedicine has improved patient access to healthcare providers, facilitating better diagnosis and adherence to prescribed treatments.
Market Segmentation
The Asia Pacific Prescription Drugs Market can be segmented based on various criteria:
Recent developments in the prescription drug market highlight ongoing innovation and strategic collaborations aimed at enhancing treatment options for chronic disorders. For instance, in May 2025, Bio-Thera Solutions, Ltd. received FDA approval for Starjemza Injection, a biosimilar used for treating various conditions, including Crohn's disease and psoriasis. Additionally, in October 2022, Pfizer Inc. acquired Biohaven Pharmaceutical Holding Company Ltd, expanding its portfolio to include treatments for migraine patients.
These developments reflect a broader trend of increasing focus on product approvals, launches, and strategic partnerships that drive innovation in the prescription drugs market. The emphasis on generic formulations is also noteworthy, as it enhances affordability and accessibility for patients. Overall, these trends are expected to significantly contribute to market growth in the near future.
Country Insights
The Asia Pacific Prescription Drugs Market is further analyzed by country, with China holding the largest market share in 2024. According to the International Diabetes Federation, China had approximately 140 million adults with diabetes in 2021, marking a 30% increase over the previous seven years. In response to these health challenges, the Chinese government has initiated the 'Healthy China 2030' plan, which promotes innovation in biotechnology and pharmaceuticals. This strategy has led to advancements in oncology and rare diseases, with domestic companies like BeiGene and Innovent Biologics developing advanced therapies that have gained international recognition. The government has also streamlined drug approval processes and expanded insurance coverage, facilitating quicker access to new treatments.
Key Players
The market features several prominent players, including GSK Plc, F. Hoffmann-La Roche Ltd, Pfizer Inc, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Novartis AG, Sanofi SA, Johnson & Johnson, AstraZeneca Plc, AbbVie Inc, and Eli Lilly and Co. These companies are actively pursuing strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and deliver innovative products to consumers.
Executive Summary and Market Analysis
A key driver of this market expansion is the region's large and aging population, which has led to an increased demand for chronic disease management and long-term medication. The rise in lifestyle-related diseases has further intensified the need for effective prescription drugs. Additionally, improvements in healthcare infrastructure and increased access to medical facilities in developing countries such as India, China, and various Southeast Asian nations have broadened the availability of prescription medications to previously underserved populations.
The growing disposable incomes and the expanding middle class in these countries have enhanced affordability and willingness to invest in healthcare, including prescription drugs. Many governments in the Asia Pacific region have prioritized healthcare reforms and increased healthcare spending, which has led to better insurance coverage and reimbursement policies that support the consumption of pharmaceuticals.
Technological advancements and the growth of research and development in the pharmaceutical sector have resulted in the introduction of innovative and targeted therapies, attracting more patients and healthcare providers to prescribed medications. The increasing awareness and adoption of modern healthcare practices, along with urbanization and lifestyle changes, have also contributed to the rising demand for prescription drugs. Furthermore, the emergence of digital health platforms and telemedicine has improved patient access to healthcare providers, facilitating better diagnosis and adherence to prescribed treatments.
Market Segmentation
The Asia Pacific Prescription Drugs Market can be segmented based on various criteria:
- By Product Type: The market is divided into Branded and Generic drugs, with Branded drugs holding the largest market share in 2024.
- By Drug Type: It is further segmented into Small Molecule drugs and Biologics/Biosimilars, where Small Molecule drugs dominate the market.
- By Therapeutic Area: The market is categorized into Oncology, Cardiovascular Diseases, Neurological Diseases, Metabolic Diseases, Respiratory Diseases, Immunology, and others, with Oncology leading in market share.
- By Route of Administration: This includes Oral, Injectable, Topical, and others, with Oral administration being the most prevalent.
- By Distribution Channel: The market is segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies, with Hospital Pharmacies holding the largest share.
Recent developments in the prescription drug market highlight ongoing innovation and strategic collaborations aimed at enhancing treatment options for chronic disorders. For instance, in May 2025, Bio-Thera Solutions, Ltd. received FDA approval for Starjemza Injection, a biosimilar used for treating various conditions, including Crohn's disease and psoriasis. Additionally, in October 2022, Pfizer Inc. acquired Biohaven Pharmaceutical Holding Company Ltd, expanding its portfolio to include treatments for migraine patients.
These developments reflect a broader trend of increasing focus on product approvals, launches, and strategic partnerships that drive innovation in the prescription drugs market. The emphasis on generic formulations is also noteworthy, as it enhances affordability and accessibility for patients. Overall, these trends are expected to significantly contribute to market growth in the near future.
Country Insights
The Asia Pacific Prescription Drugs Market is further analyzed by country, with China holding the largest market share in 2024. According to the International Diabetes Federation, China had approximately 140 million adults with diabetes in 2021, marking a 30% increase over the previous seven years. In response to these health challenges, the Chinese government has initiated the 'Healthy China 2030' plan, which promotes innovation in biotechnology and pharmaceuticals. This strategy has led to advancements in oncology and rare diseases, with domestic companies like BeiGene and Innovent Biologics developing advanced therapies that have gained international recognition. The government has also streamlined drug approval processes and expanded insurance coverage, facilitating quicker access to new treatments.
Key Players
The market features several prominent players, including GSK Plc, F. Hoffmann-La Roche Ltd, Pfizer Inc, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Novartis AG, Sanofi SA, Johnson & Johnson, AstraZeneca Plc, AbbVie Inc, and Eli Lilly and Co. These companies are actively pursuing strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and deliver innovative products to consumers.
1. INTRODUCTION
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. PRESCRIPTION DRUGS MARKET LANDSCAPE
4.1 PEST Analysis
5. ASIA PACIFIC PRESCRIPTION DRUGS MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. PRESCRIPTION DRUGS MARKET - ASIA PACIFIC MARKET ANALYSIS
6.1 Asia Pacific Prescription Drugs Market Revenue (US$ Billion), 2024 - 2031
6.2 Asia Pacific Prescription Drugs Market Forecast and Analysis
7. ASIA PACIFIC PRESCRIPTION DRUGS MARKET REVENUE ANALYSIS - BY PRODUCT TYPE
7.1 Branded
7.1.1 Overview
7.1.2 Branded: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
7.2 Generics
7.2.1 Overview
7.2.2 Generics: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
8. ASIA PACIFIC PRESCRIPTION DRUGS MARKET REVENUE ANALYSIS - BY DRUG TYPE
8.1 Small Molecule
8.1.1 Overview
8.1.2 Small Molecule: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
8.2 Biologics and Biosimilar
8.2.1 Overview
8.2.2 Biologics and Biosimilar: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9. ASIA PACIFIC PRESCRIPTION DRUGS MARKET REVENUE ANALYSIS - BY THERAPEUTIC AREA
9.1 Oncology
9.1.1 Overview
9.1.2 Oncology: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9.2 Cardiovascular Diseases
9.2.1 Overview
9.2.2 Cardiovascular Diseases: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9.3 Neurological Diseases
9.3.1 Overview
9.3.2 Neurological Diseases: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9.4 Metabolic Diseases
9.4.1 Overview
9.4.2 Metabolic Diseases: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9.5 Respiratory Diseases
9.5.1 Overview
9.5.2 Respiratory Diseases: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9.6 Immunology
9.6.1 Overview
9.6.2 Immunology: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9.7 Others
9.7.1 Overview
9.7.2 Others: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
10. ASIA PACIFIC PRESCRIPTION DRUGS MARKET REVENUE ANALYSIS - BY ROUTE OF ADMINISTRATION
10.1 Oral
10.1.1 Overview
10.1.2 Oral: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
10.2 Injectable
10.2.1 Overview
10.2.2 Injectable: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
10.3 Topical
10.3.1 Overview
10.3.2 Topical: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
10.4 Others
10.4.1 Overview
10.4.2 Others: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
11. ASIA PACIFIC PRESCRIPTION DRUGS MARKET REVENUE ANALYSIS - BY DISTRIBUTION CHANNEL
11.1 Hospital Pharmacies
11.1.1 Overview
11.1.2 Hospital Pharmacies: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
11.2 Retail Pharmacies
11.2.1 Overview
11.2.2 Retail Pharmacies: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
11.3 Online Pharmacies
11.3.1 Overview
11.3.2 Online Pharmacies: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
12. ASIA PACIFIC PRESCRIPTION DRUGS MARKET - COUNTRY ANALYSIS
12.1 Asia Pacific
12.1.1 Asia Pacific Prescription Drugs Market Revenue and Forecast and Analysis - by Country
12.1.1.1 Asia Pacific Prescription Drugs Market Revenue and Forecast and Analysis - by Country
12.1.2.2 China: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
12.1.2.2.1 China: Asia Pacific Prescription Drugs Market Share - by Product Type
12.1.2.2.2 China: Asia Pacific Prescription Drugs Market Share - by Drug Type
12.1.2.2.3 China: Asia Pacific Prescription Drugs Market Share - by Therapeutic Area
12.1.2.2.4 China: Asia Pacific Prescription Drugs Market Share - by Route Of Administration
12.1.2.2.5 China: Asia Pacific Prescription Drugs Market Share - by Distribution Channel
12.2.3.3 Japan: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
12.2.3.3.1 Japan: Asia Pacific Prescription Drugs Market Share - by Product Type
12.2.3.3.2 Japan: Asia Pacific Prescription Drugs Market Share - by Drug Type
12.2.3.3.3 Japan: Asia Pacific Prescription Drugs Market Share - by Therapeutic Area
12.2.3.3.4 Japan: Asia Pacific Prescription Drugs Market Share - by Route Of Administration
12.2.3.3.5 Japan: Asia Pacific Prescription Drugs Market Share - by Distribution Channel
12.3.4.4 India: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
12.3.4.4.1 India: Asia Pacific Prescription Drugs Market Share - by Product Type
12.3.4.4.2 India: Asia Pacific Prescription Drugs Market Share - by Drug Type
12.3.4.4.3 India: Asia Pacific Prescription Drugs Market Share - by Therapeutic Area
12.3.4.4.4 India: Asia Pacific Prescription Drugs Market Share - by Route Of Administration
12.3.4.4.5 India: Asia Pacific Prescription Drugs Market Share - by Distribution Channel
12.4.5.5 Australia: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
12.4.5.5.1 Australia: Asia Pacific Prescription Drugs Market Share - by Product Type
12.4.5.5.2 Australia: Asia Pacific Prescription Drugs Market Share - by Drug Type
12.4.5.5.3 Australia: Asia Pacific Prescription Drugs Market Share - by Therapeutic Area
12.4.5.5.4 Australia: Asia Pacific Prescription Drugs Market Share - by Route Of Administration
12.4.5.5.5 Australia: Asia Pacific Prescription Drugs Market Share - by Distribution Channel
12.5.6.6 South Korea: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
12.5.6.6.1 South Korea: Asia Pacific Prescription Drugs Market Share - by Product Type
12.5.6.6.2 South Korea: Asia Pacific Prescription Drugs Market Share - by Drug Type
12.5.6.6.3 South Korea: Asia Pacific Prescription Drugs Market Share - by Therapeutic Area
12.5.6.6.4 South Korea: Asia Pacific Prescription Drugs Market Share - by Route Of Administration
12.5.6.6.5 South Korea: Asia Pacific Prescription Drugs Market Share - by Distribution Channel
12.6.7.7 Rest of APAC: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
12.6.7.7.1 Rest of APAC: Asia Pacific Prescription Drugs Market Share - by Product Type
12.6.7.7.2 Rest of APAC: Asia Pacific Prescription Drugs Market Share - by Drug Type
12.6.7.7.3 Rest of APAC: Asia Pacific Prescription Drugs Market Share - by Therapeutic Area
12.6.7.7.4 Rest of APAC: Asia Pacific Prescription Drugs Market Share - by Route Of Administration
12.6.7.7.5 Rest of APAC: Asia Pacific Prescription Drugs Market Share - by Distribution Channel
13 COMPETITIVE LANDSCAPE
13.1 Heat Map Analysis by Key Players
13.2 Company Positioning & Concentration
14 INDUSTRY LANDSCAPE
14.1 Overview
14.2 New Product Development
14.3 Merger and Acquisition
14.4 Other Strategic Developments
15 COMPANY PROFILES
15.1 GSK Plc
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 F. Hoffmann-La Roche Ltd
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Pfizer Inc
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 Merck & Co Inc
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 Teva Pharmaceutical Industries Ltd
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Novartis AG
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Sanofi SA
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 Johnson & Johnson
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 AstraZeneca Plc
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 AbbVie Inc
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Products and Services
15.10.4 Financial Overview
15.10.5 SWOT Analysis
15.10.6 Key Developments
15.11 Eli Lilly and Co
15.11.1 Key Facts
15.11.2 Business Description
15.11.3 Products and Services
15.11.4 Financial Overview
15.11.5 SWOT Analysis
15.11.6 Key Developments
15.12 ESTEVE
15.12.1 Key Facts
15.12.2 Business Description
15.12.3 Products and Services
15.12.4 Financial Overview
15.12.5 SWOT Analysis
15.12.6 Key Developments
16. APPENDIX
16.1 About The Insight Partners
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. PRESCRIPTION DRUGS MARKET LANDSCAPE
4.1 PEST Analysis
5. ASIA PACIFIC PRESCRIPTION DRUGS MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. PRESCRIPTION DRUGS MARKET - ASIA PACIFIC MARKET ANALYSIS
6.1 Asia Pacific Prescription Drugs Market Revenue (US$ Billion), 2024 - 2031
6.2 Asia Pacific Prescription Drugs Market Forecast and Analysis
7. ASIA PACIFIC PRESCRIPTION DRUGS MARKET REVENUE ANALYSIS - BY PRODUCT TYPE
7.1 Branded
7.1.1 Overview
7.1.2 Branded: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
7.2 Generics
7.2.1 Overview
7.2.2 Generics: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
8. ASIA PACIFIC PRESCRIPTION DRUGS MARKET REVENUE ANALYSIS - BY DRUG TYPE
8.1 Small Molecule
8.1.1 Overview
8.1.2 Small Molecule: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
8.2 Biologics and Biosimilar
8.2.1 Overview
8.2.2 Biologics and Biosimilar: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9. ASIA PACIFIC PRESCRIPTION DRUGS MARKET REVENUE ANALYSIS - BY THERAPEUTIC AREA
9.1 Oncology
9.1.1 Overview
9.1.2 Oncology: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9.2 Cardiovascular Diseases
9.2.1 Overview
9.2.2 Cardiovascular Diseases: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9.3 Neurological Diseases
9.3.1 Overview
9.3.2 Neurological Diseases: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9.4 Metabolic Diseases
9.4.1 Overview
9.4.2 Metabolic Diseases: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9.5 Respiratory Diseases
9.5.1 Overview
9.5.2 Respiratory Diseases: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9.6 Immunology
9.6.1 Overview
9.6.2 Immunology: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9.7 Others
9.7.1 Overview
9.7.2 Others: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
10. ASIA PACIFIC PRESCRIPTION DRUGS MARKET REVENUE ANALYSIS - BY ROUTE OF ADMINISTRATION
10.1 Oral
10.1.1 Overview
10.1.2 Oral: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
10.2 Injectable
10.2.1 Overview
10.2.2 Injectable: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
10.3 Topical
10.3.1 Overview
10.3.2 Topical: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
10.4 Others
10.4.1 Overview
10.4.2 Others: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
11. ASIA PACIFIC PRESCRIPTION DRUGS MARKET REVENUE ANALYSIS - BY DISTRIBUTION CHANNEL
11.1 Hospital Pharmacies
11.1.1 Overview
11.1.2 Hospital Pharmacies: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
11.2 Retail Pharmacies
11.2.1 Overview
11.2.2 Retail Pharmacies: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
11.3 Online Pharmacies
11.3.1 Overview
11.3.2 Online Pharmacies: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
12. ASIA PACIFIC PRESCRIPTION DRUGS MARKET - COUNTRY ANALYSIS
12.1 Asia Pacific
12.1.1 Asia Pacific Prescription Drugs Market Revenue and Forecast and Analysis - by Country
12.1.1.1 Asia Pacific Prescription Drugs Market Revenue and Forecast and Analysis - by Country
12.1.2.2 China: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
12.1.2.2.1 China: Asia Pacific Prescription Drugs Market Share - by Product Type
12.1.2.2.2 China: Asia Pacific Prescription Drugs Market Share - by Drug Type
12.1.2.2.3 China: Asia Pacific Prescription Drugs Market Share - by Therapeutic Area
12.1.2.2.4 China: Asia Pacific Prescription Drugs Market Share - by Route Of Administration
12.1.2.2.5 China: Asia Pacific Prescription Drugs Market Share - by Distribution Channel
12.2.3.3 Japan: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
12.2.3.3.1 Japan: Asia Pacific Prescription Drugs Market Share - by Product Type
12.2.3.3.2 Japan: Asia Pacific Prescription Drugs Market Share - by Drug Type
12.2.3.3.3 Japan: Asia Pacific Prescription Drugs Market Share - by Therapeutic Area
12.2.3.3.4 Japan: Asia Pacific Prescription Drugs Market Share - by Route Of Administration
12.2.3.3.5 Japan: Asia Pacific Prescription Drugs Market Share - by Distribution Channel
12.3.4.4 India: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
12.3.4.4.1 India: Asia Pacific Prescription Drugs Market Share - by Product Type
12.3.4.4.2 India: Asia Pacific Prescription Drugs Market Share - by Drug Type
12.3.4.4.3 India: Asia Pacific Prescription Drugs Market Share - by Therapeutic Area
12.3.4.4.4 India: Asia Pacific Prescription Drugs Market Share - by Route Of Administration
12.3.4.4.5 India: Asia Pacific Prescription Drugs Market Share - by Distribution Channel
12.4.5.5 Australia: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
12.4.5.5.1 Australia: Asia Pacific Prescription Drugs Market Share - by Product Type
12.4.5.5.2 Australia: Asia Pacific Prescription Drugs Market Share - by Drug Type
12.4.5.5.3 Australia: Asia Pacific Prescription Drugs Market Share - by Therapeutic Area
12.4.5.5.4 Australia: Asia Pacific Prescription Drugs Market Share - by Route Of Administration
12.4.5.5.5 Australia: Asia Pacific Prescription Drugs Market Share - by Distribution Channel
12.5.6.6 South Korea: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
12.5.6.6.1 South Korea: Asia Pacific Prescription Drugs Market Share - by Product Type
12.5.6.6.2 South Korea: Asia Pacific Prescription Drugs Market Share - by Drug Type
12.5.6.6.3 South Korea: Asia Pacific Prescription Drugs Market Share - by Therapeutic Area
12.5.6.6.4 South Korea: Asia Pacific Prescription Drugs Market Share - by Route Of Administration
12.5.6.6.5 South Korea: Asia Pacific Prescription Drugs Market Share - by Distribution Channel
12.6.7.7 Rest of APAC: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
12.6.7.7.1 Rest of APAC: Asia Pacific Prescription Drugs Market Share - by Product Type
12.6.7.7.2 Rest of APAC: Asia Pacific Prescription Drugs Market Share - by Drug Type
12.6.7.7.3 Rest of APAC: Asia Pacific Prescription Drugs Market Share - by Therapeutic Area
12.6.7.7.4 Rest of APAC: Asia Pacific Prescription Drugs Market Share - by Route Of Administration
12.6.7.7.5 Rest of APAC: Asia Pacific Prescription Drugs Market Share - by Distribution Channel
13 COMPETITIVE LANDSCAPE
13.1 Heat Map Analysis by Key Players
13.2 Company Positioning & Concentration
14 INDUSTRY LANDSCAPE
14.1 Overview
14.2 New Product Development
14.3 Merger and Acquisition
14.4 Other Strategic Developments
15 COMPANY PROFILES
15.1 GSK Plc
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 F. Hoffmann-La Roche Ltd
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Pfizer Inc
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 Merck & Co Inc
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 Teva Pharmaceutical Industries Ltd
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Novartis AG
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Sanofi SA
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 Johnson & Johnson
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 AstraZeneca Plc
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 AbbVie Inc
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Products and Services
15.10.4 Financial Overview
15.10.5 SWOT Analysis
15.10.6 Key Developments
15.11 Eli Lilly and Co
15.11.1 Key Facts
15.11.2 Business Description
15.11.3 Products and Services
15.11.4 Financial Overview
15.11.5 SWOT Analysis
15.11.6 Key Developments
15.12 ESTEVE
15.12.1 Key Facts
15.12.2 Business Description
15.12.3 Products and Services
15.12.4 Financial Overview
15.12.5 SWOT Analysis
15.12.6 Key Developments
16. APPENDIX
16.1 About The Insight Partners
LIST OF TABLES
Table 1. Asia Pacific Prescription Drugs Market Segmentation
Table 3. Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Table 4. Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Product Type
Table 5. Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Drug Type
Table 6. Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Therapeutic Area
Table 7. Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Route Of Administration
Table 8. Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Distribution Channel
Table 9. Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Country
Table 10. China: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Product Type
Table 11. China: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Drug Type
Table 12. China: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Therapeutic Area
Table 13. China: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Route Of Administration
Table 14. China: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Distribution Channel
Table 15. Japan: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Product Type
Table 16. Japan: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Drug Type
Table 17. Japan: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Therapeutic Area
Table 18. Japan: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Route Of Administration
Table 19. Japan: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Distribution Channel
Table 20. India: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Product Type
Table 21. India: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Drug Type
Table 22. India: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Therapeutic Area
Table 23. India: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Route Of Administration
Table 24. India: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Distribution Channel
Table 25. Australia: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Product Type
Table 26. Australia: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Drug Type
Table 27. Australia: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Therapeutic Area
Table 28. Australia: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Route Of Administration
Table 29. Australia: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Distribution Channel
Table 30. South Korea: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Product Type
Table 31. South Korea: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Drug Type
Table 32. South Korea: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Therapeutic Area
Table 33. South Korea: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Route Of Administration
Table 34. South Korea: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Distribution Channel
Table 35. Rest of APAC: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Product Type
Table 36. Rest of APAC: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Drug Type
Table 37. Rest of APAC: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Therapeutic Area
Table 38. Rest of APAC: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Route Of Administration
Table 39. Rest of APAC: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Distribution Channel
Table 40. Heat Map Analysis by Key Players
Table 1. Asia Pacific Prescription Drugs Market Segmentation
Table 3. Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Table 4. Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Product Type
Table 5. Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Drug Type
Table 6. Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Therapeutic Area
Table 7. Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Route Of Administration
Table 8. Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Distribution Channel
Table 9. Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Country
Table 10. China: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Product Type
Table 11. China: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Drug Type
Table 12. China: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Therapeutic Area
Table 13. China: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Route Of Administration
Table 14. China: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Distribution Channel
Table 15. Japan: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Product Type
Table 16. Japan: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Drug Type
Table 17. Japan: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Therapeutic Area
Table 18. Japan: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Route Of Administration
Table 19. Japan: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Distribution Channel
Table 20. India: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Product Type
Table 21. India: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Drug Type
Table 22. India: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Therapeutic Area
Table 23. India: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Route Of Administration
Table 24. India: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Distribution Channel
Table 25. Australia: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Product Type
Table 26. Australia: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Drug Type
Table 27. Australia: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Therapeutic Area
Table 28. Australia: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Route Of Administration
Table 29. Australia: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Distribution Channel
Table 30. South Korea: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Product Type
Table 31. South Korea: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Drug Type
Table 32. South Korea: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Therapeutic Area
Table 33. South Korea: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Route Of Administration
Table 34. South Korea: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Distribution Channel
Table 35. Rest of APAC: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Product Type
Table 36. Rest of APAC: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Drug Type
Table 37. Rest of APAC: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Therapeutic Area
Table 38. Rest of APAC: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Route Of Administration
Table 39. Rest of APAC: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Distribution Channel
Table 40. Heat Map Analysis by Key Players
LIST OF FIGURES
Figure 1. Asia Pacific Prescription Drugs Market Segmentation - Country
Figure 2. PEST Analysis
Figure 4. Asia Pacific Prescription Drugs Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Asia Pacific Prescription Drugs Market Revenue (US$ Billion), 2024 - 2031
Figure 7. Asia Pacific Prescription Drugs Market Share (%) - by Product Type, 2024 and 2031
Figure 8. Branded: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 9. Generics: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 10. Asia Pacific Prescription Drugs Market Share (%) - by Drug Type, 2024 and 2031
Figure 11. Small Molecule: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 12. Biologics and Biosimilar: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 13. Asia Pacific Prescription Drugs Market Share (%) - by Therapeutic Area, 2024 and 2031
Figure 14. Oncology: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 15. Cardiovascular Diseases: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 16. Neurological Diseases: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 17. Metabolic Diseases: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 18. Respiratory Diseases: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 19. Immunology: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 20. Others: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 21. Asia Pacific Prescription Drugs Market Share (%) - by Route Of Administration, 2024 and 2031
Figure 22. Oral: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 23. Injectable: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 24. Topical: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 25. Others: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 26. Asia Pacific Prescription Drugs Market Share (%) - by Distribution Channel, 2024 and 2031
Figure 27. Hospital Pharmacies: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 28. Retail Pharmacies: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 29. Online Pharmacies: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 30. Asia Pacific Prescription Drugs Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 31. China: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 32. Japan: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 33. India: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 34. Australia: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 35. South Korea: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 36. Rest of APAC: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 37. Company Positioning & Concentration
Figure 1. Asia Pacific Prescription Drugs Market Segmentation - Country
Figure 2. PEST Analysis
Figure 4. Asia Pacific Prescription Drugs Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Asia Pacific Prescription Drugs Market Revenue (US$ Billion), 2024 - 2031
Figure 7. Asia Pacific Prescription Drugs Market Share (%) - by Product Type, 2024 and 2031
Figure 8. Branded: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 9. Generics: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 10. Asia Pacific Prescription Drugs Market Share (%) - by Drug Type, 2024 and 2031
Figure 11. Small Molecule: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 12. Biologics and Biosimilar: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 13. Asia Pacific Prescription Drugs Market Share (%) - by Therapeutic Area, 2024 and 2031
Figure 14. Oncology: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 15. Cardiovascular Diseases: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 16. Neurological Diseases: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 17. Metabolic Diseases: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 18. Respiratory Diseases: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 19. Immunology: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 20. Others: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 21. Asia Pacific Prescription Drugs Market Share (%) - by Route Of Administration, 2024 and 2031
Figure 22. Oral: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 23. Injectable: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 24. Topical: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 25. Others: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 26. Asia Pacific Prescription Drugs Market Share (%) - by Distribution Channel, 2024 and 2031
Figure 27. Hospital Pharmacies: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 28. Retail Pharmacies: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 29. Online Pharmacies: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 30. Asia Pacific Prescription Drugs Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 31. China: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 32. Japan: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 33. India: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 34. Australia: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 35. South Korea: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 36. Rest of APAC: Asia Pacific Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 37. Company Positioning & Concentration
